Kyowa Kirin gets EC approval for CRYSVITA (burosumab) to treat X-Linked hypophosphataemia in older… EP News Bureau Oct 2, 2020 It was previously approved for the treatment of XLH with radiographic evidence of bone disease in children one year of age and…
